Post by Apoha

Next-gen antibodies need next-gen insights.  Are the industries developability tools keeping up? On a recent episode of The CHAIN Podcast, our CEO Shamit Shrivastava sat down with Nimish Gera to talk about this exact gap, and how Apoha’s Liquid Brain® is changing the game. The most critical data is still missing: how a molecule behaves, in motion, in context, in real time. The Liquid Brain® is the first machine that can feel molecules, providing high-dimensional insights that open entirely new ways to design and assess complex antibody drugs. Shamit also shared an exciting sneak peek of what’s next for us at #PEGSEurope this November (who else is going to be there?). This episode is worth a listen to hear how we are pushing the boundaries of developability! #LiquidBrain #AntibodyDevelopability #DrugDiscovery #DeepTech #PEGS

Video Content